Dr. Charlie Roberts, MBChB
Machine learning, enabled by high dimensional omic data that has never before existed, brings unprecedented opportunities to understand and modulate biology. The close community, scientific rigour, and data from the deep ecosystem at Juvenescence confers great firepower to deliver on this vision.
Dr. Charlie Roberts, MBChB is a co-founder and the Chief Growth Officer at Freenome, a company that uses statistical learning methods to understand the plasma genome for cancer detection and more.
Dr. Roberts was co-founder and director of Yourgene Health (LSE:YGEN), Agalimmune, an immunotherapy company acquired by a Nasdaq company, and Centauri Therapeutics Ltd. Dr. Roberts also trained in reconstructive and oncologic-reconstructive surgery with the National Health Services in the UK.
Dr. Roberts has a BSc in psychology from University College London (UCL), an MSc in experimental therapeutics from Oxford University and an MB medical degree from the University of Dundee in Scotland.